Tracking binding modes of 1,2,4-trisubstituted imidazolinone P38 MAP kinase and ERK-2 inhibitors

被引:3
|
作者
Rao, Shashidhar N. [1 ]
机构
[1] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
关键词
p38 MAP Kinase; ERK-2; Docking score; DFG-out; Hydrogen bonding; Spearman-R correlation; pi-Cation interactions; ACTIVATED PROTEIN-KINASE; PANCREATIC-CANCER; DOCKING; IDENTIFICATION; DERIVATIVES; PATHWAYS; DESIGN; SMILES; ERK1/2; CELLS;
D O I
10.1016/j.jmgm.2017.07.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Putative binding modes of recently reported p38 MAP Kinase and ERK-2 inhibitors containing 1,2,4-trisubstituted imidazolinone have been investigated using molecular docking methods In the case of p38 MAP Kinase, X-ray structures with both DFG-in and DFG-out conformations of the activation loop have been employed for docking studies. The present investigations demonstrate that the DFG-out conformation of the activation loop in p38 MAP Kinase accommodates the 1,2,4-tri-substituted imidazolinones with greater computed binding affinities than the alternative DFG-in conformation. The best scoring binding modes in ERK-2 are distinctly different from those found in the p38 MAP Kinase structures. Both sets of binding modes are characterized by an extensive network of hydrophobic and pi-cation interactions, with the hinge region showing little hydrogen bonding propensity with the top-ranked poses. Thus, these docking studies provide a putative pathway for lead optimizations in which hydrogen bonding interactions with the hinge region residues are feasible. (c) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 50 条
  • [21] Design and synthesis of novel p38α MAP kinase inhibitors: Discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety
    Arai, Tadamasa
    Ohno, Michihiro
    Inoue, Hideki
    Hayashi, Shinnosuke
    Aoki, Takumi
    Hirokawa, Hiroe
    Meguro, Hiroyuki
    Koga, Yoko
    Oshida, Keiyu
    Kainoh, Mie
    Suyama, Kazuharu
    Kawai, Hideki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 5118 - 5122
  • [22] ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
    Sosa, Maria Soledad
    Avivar-Valderas, Alvaro
    Bragado, Paloma
    Wen, Huei-Chi
    Aguirre-Ghiso, Julio A.
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 5850 - 5857
  • [23] Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro
    Singh, R. K.
    Diwan, M.
    Dastidar, S. G.
    Najmi, A. K.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2018, 37 (05) : 521 - 531
  • [24] Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase
    Iida, Yuko
    Doi, Tomoaki
    Tokuda, Haruhiko
    Matsushima-Nishiwaki, Rie
    Tsujimoto, Masanori
    Kuroyanagi, Gen
    Yamamoto, Naohiro
    Enomoto, Yukiko
    Tanabe, Kumiko
    Otsuka, Takanobu
    Iwama, Toru
    Ogura, Shinji
    Kozawa, Osamu
    Iida, Hiroki
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2015, 94 : 73 - 81
  • [25] Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase
    He, Zhao
    Zhu, Helen H.
    Bauler, Timothy J.
    Wang, Jing
    Ciaraldi, Theodore
    Alderson, Nazilla
    Li, Shuangwei
    Raquil, Marie-Astrid
    Ji, Kaihong
    Wang, Shufen
    Shao, Jianhua
    Henry, Robert R.
    King, Philip D.
    Feng, Gen-Sheng
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (01) : E79 - E88
  • [26] Indolin-2-one p38α inhibitors I: Design, profiling and crystallographic binding mode
    Eastwood, Paul
    Gonzalez, Jacob
    Gomez, Elena
    Vidal, Bernat
    Caturla, Francisco
    Roca, Ramon
    Balague, Cristina
    Orellana, Adelina
    Dominguez, Maria
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4130 - 4133
  • [27] IGF2BP1: a novel binding protein of p38 MAPK
    Rini, Jacob
    Anbalagan, Moorthy
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2017, 435 (1-2) : 133 - 140
  • [28] Pneumolysin-Mediated Expression of β-Defensin 2 Is Coordinated by p38 MAP Kinase-MKP1 in Human Airway Cells
    Kim, Yong-Jae
    Shin, Hee-Sung
    Lee, Jung-Hoon
    Jung, Yong Woo
    Kim, Hyong-Bai
    Ha, Un-Hwan
    JOURNAL OF MICROBIOLOGY, 2013, 51 (02) : 194 - 199
  • [29] Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma
    Lin, Sijie
    Liu, Kuancan
    Zhang, Yongchun
    Jiang, Ming
    Lu, Rong
    Folts, Christopher J.
    Gao, Xia
    Noble, Mark D.
    Zhao, Tingting
    Zhou, Zhongren
    Lan, Xiaopeng
    Que, Jianwen
    CELLULAR SIGNALLING, 2018, 51 : 222 - 232
  • [30] Structure-based design, synthesis, and biological evaluation of imidazo [1,2-b]pyridazine-based p38 MAP kinase inhibitors
    Kaieda, Akira
    Takahashi, Masashi
    Takai, Takafumi
    Goto, Masayuki
    Miyazaki, Takahiro
    Hori, Yuri
    Unno, Satoko
    Kawamoto, Tomohiro
    Tanaka, Toshimasa
    Itono, Sachiko
    Takagi, Terufumi
    Hamada, Teruki
    Shirasaki, Mikio
    Okada, Kengo
    Snell, Gyorgy
    Bragstad, Ken
    Sang, Bi-Ching
    Uchikawa, Osamu
    Miwatashi, Seiji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (03) : 647 - 660